Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Prevalence of Gout and Hyperuricemia Increase in U.S.

Sue Pondrom  |  January 18, 2012

Using data from the National Health and Nutrition Examination Survey (NHANES) 2007-2008, researchers have shown that the prevalence of gout in the United States has increased to 3.9% (8.3 million Americans) compared with 2.7% in NHANES-III, which covered the period of 1988-1994. Additionally, the prevalence of hyperuricemia was 21.4%, or about 43.3 million individuals, and significantly higher than in NHAMES III, with an unadjusted difference of 3.2%.

The study, which included 5,707 participants and was published in Arthritis & Rheumatism, noted that the NHANES surveys combined interviews, physical examinations, and various laboratory data to reach conclusions about the prevalence of diseases in this time period.1 The 1988-1994 study period included 18,825 patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The article indicated that the prevalence of gout was highest in men and seniors at 5.9% and 9.8%, respectively. For women, it was 2%. Hyperuricemia, on the other hand, was nearly equal in the sexes: 21.2% among men and 21.6% among women. The prevalence increased with age, up to 31.4% in people ages 65 years or older.

H. Ralph Schumacher, Jr., MD, professor of medicine at the University of Pennsylvania in Philadelphia, who is not associated with the research, says that the study “addressed prevalence, not incidence, and actually suggested very little increase in the last 20 years.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Schumacher also says that the study indicates the data were based on a telephone report “and that a doctor told them they had gout. So, estimates [of gout cases made in the research] may be high, but gout is certainly still a problem.” He adds that, “they considered a lower level of SUA [serum uric acid] as hyperuricemic in women.”

The authors of the study commented that, “according to the data gathered [in NHANES-III], the disease burden of gout was already substantial and increasing worldwide… Western diets, sedentary lifestyle, an increased frequency of obesity and hypertension, and increased use of diuretics and aspirin have been suspected to contribute to the increase before the new millennium,” with the same causes suspected in the newer survey.

They added that the substantial prevalence of both gout and hyperuricemia “has been sustained during the last two decades and indeed may still be increasing.”

The authors suggested that, “modifiable risk factors for gout and hyperuricemia include lifestyle and dietary factors (obesity, alcohol, fructose, purine-rich fatty food), certain drugs (thiazide and loop diuretics), and disease conditions (hypertension, renal insufficiency, and heart failure).” Additionally, “heavy drinking should be avoided.”

Sue Pondrom is a medical journalist based in San Diego.

Reference

1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63:3136-3141.

 

Page: 1 2 | Multi-Page
Share: 

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:AlcoholDietGoutObesity

Related Articles

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    Treating Asymptomatic Hyperuricemia Could Lower Risk of Developing Chronic Conditions

    August 12, 2016

    g0d4ather/shutterstock.com When uric acid becomes elevated in the human body, a variety of problems can develop, most notably gout—a painful, inflammatory arthritis caused by uric acid crystal deposition in joints. Chronically elevated uric acid can also lead to painful kidney stones. The majority of patients found to have hyperuricemia, however, never go on to develop…

    Contemporary Prevalence of Gout & Hyperuricemia in the U.S.

    May 31, 2019

    Using 2007–2016 data from NHANES, a nationally representative survey of American men and women, Chen-Xu et al. set out to estimate the current prevalence rates and decadal trends of gout and hyperuricemia in the U.S.

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences